Brief: Aarti Pharmalabs- Expect EBITDA Growth Of About 10-12% In FY25

Aarti Pharmalabs

15/05/2024 06:00

May 15 (Reuters) - Aarti Pharmalabs Ltd  AARP.NS :
    * AARTI PHARMALABS LTD-  COMMERCIALIZATION OF ATALI PROJECT
EXPANSION EXPECTED IN Q4FY25
    * AARTI PHARMALABS LTD-  EXPECT EBITDA GROWTH OF ABOUT
10-12% IN
FY25
    * AARTI PHARMALABS LTD-  AIM TO ACHIEVE LONG-TERM GOAL OF
OVER 15%
 ANNUAL GROWTH IN NEXT 3 YEARS

Source text for Eikon:  ID:nBSE6Dv9rD 
Further company coverage:  AARP.NS 

 ((Reuters.Briefs@thomsonreuters.com;))